Summarizing current health news, Dr. Oz, Trump's Medicare nominee, will not oppose Medicaid cuts, FDA gives flu vaccine ...

Recent health news covers Dr. Oz's stance on Medicaid cuts, the US FDA's influenza vaccine strain recommendations, ...

The home of a prominent Bayer executive was targeted last week in an alleged arson in New Jersey, law enforcement sources ...

In a live event, Ganesh V. Raj, MD, PhD, discussed the drug-drug interactions and outcomes by disease volumes across ARPI ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

Paris Saint-Germain held their nerve to beat Liverpool 4-1 on penalties and reach the Champions League quarter-finals on Tuesday after their tie finished one-apiece on aggregate, while Bayern Munich s ...

Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

Q4 2024 Earnings Call Transcript March 6, 2025 Evogene Ltd. beats earnings expectations. Reported EPS is $0.06, expectations ...

Bayer has paid about $10 billion to settle disputed claims that Roundup, based on the herbicide glyphosate, causes cancer.

CEO Bill Anderson warned investors that profits will decline in 2025 before the company’s ongoing shake-up leads to an “improved trajectory” next year.

Bayer's CEO is facing increasing investor pressure to deliver on turnaround efforts and reverse a forecast earnings decline ...